aluates Reports

$ 0.0

Automative

Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-31K13063

Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon DEB Catheters Market Research Report 2023

BUY CHAPTERS

Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Research Report 2025

Code: QYRE-Auto-31K13063

Report

August 2025

Pages:69

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Boston Scientific

Nano Therapeutics Pvt Ltd

BARD

Medtronic Inc

B Braun Melsungen AG

Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size

The global market for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters was valued at US$ 213 million in the year 2024 and is projected to reach a revised size of US$ 326 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market

Percutaneous transluminal coronary angioplasty (PTCA) is a minimally-invasive procedure used to open blocked or narrowed coronary arteries.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters.

The Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Report

Report Metric	Details
Report Name	Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market
Accounted market size in year	US$ 213 million
Forecasted market size in 2031	US$ 326 million
CAGR	6.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Length, ≤10mm Length, ＞10mm
Segment by Application	Hospitals Clinics Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Boston Scientific, Nano Therapeutics Pvt Ltd, Bard, Medtronic, B. Braun Melsungen AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market growing?

Ans: The Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market size in 2031?

Ans: The Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market size in 2031 will be US$ 326 million.

Who are the main players in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market report?

Ans: The main players in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market are Boston Scientific, Nano Therapeutics Pvt Ltd, Bard, Medtronic, B. Braun Melsungen AG

What are the Application segmentation covered in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market report?

Ans: The Applications covered in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market report?

Ans: The Types covered in the Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market report are Length, ≤10mm, Length, ＞10mm

Recommended Reports

Balloon Catheter Devices

Drug-Eluting Technology

Angioplasty Related

1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Overview

1.1 Product Definition

1.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Type

1.2.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value Comparison by Type (2024 VS 2031)

1.2.2 Length, ≤10mm

1.2.3 Length, ＞10mm

1.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Application

1.3.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size Estimates and Forecasts

1.4.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue 2020-2031

1.4.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales 2020-2031

1.4.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Competition by Manufacturers

2.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Manufacturers (2020-2025)

2.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Product Type & Application

2.7 Global Key Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Date of Enter into This Industry

2.8 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Competitive Situation and Trends

2.8.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Players Market Share by Revenue

2.8.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Scenario by Region

3.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region: 2020-2031

3.2.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region: 2020-2025

3.2.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region: 2026-2031

3.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region: 2020-2031

3.3.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region: 2020-2025

3.3.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region: 2026-2031

3.4 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Facts & Figures by Country

3.4.1 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2020-2031)

3.4.3 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.4.6 Mexico

3.5 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Facts & Figures by Country

3.5.1 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2020-2031)

3.5.3 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 UK

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Facts & Figures by Region

3.6.1 Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region (2020-2031)

3.6.3 Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Facts & Figures by Country

3.7.1 Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2020-2031)

3.7.3 Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Facts & Figures by Country

3.8.1 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2020-2031)

3.8.3 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Type (2020-2031)

4.1.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Type (2020-2025)

4.1.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Type (2026-2031)

4.1.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Type (2020-2031)

4.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Type (2020-2031)

4.2.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Type (2020-2025)

4.2.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Type (2026-2031)

4.2.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Type (2020-2031)

4.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price by Type (2020-2031)

5 Segment by Application

5.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Application (2020-2031)

5.1.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Application (2020-2025)

5.1.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Application (2026-2031)

5.1.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Application (2020-2031)

5.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Application (2020-2031)

5.2.1 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Application (2020-2025)

5.2.2 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Application (2026-2031)

5.2.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Application (2020-2031)

5.3 Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Boston Scientific

6.1.1 Boston Scientific Company Information

6.1.2 Boston Scientific Description and Business Overview

6.1.3 Boston Scientific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Boston Scientific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product Portfolio

6.1.5 Boston Scientific Recent Developments/Updates

6.2 Nano Therapeutics Pvt Ltd

6.2.1 Nano Therapeutics Pvt Ltd Company Information

6.2.2 Nano Therapeutics Pvt Ltd Description and Business Overview

6.2.3 Nano Therapeutics Pvt Ltd Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Nano Therapeutics Pvt Ltd Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product Portfolio

6.2.5 Nano Therapeutics Pvt Ltd Recent Developments/Updates

6.3 Bard

6.3.1 Bard Company Information

6.3.2 Bard Description and Business Overview

6.3.3 Bard Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Bard Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product Portfolio

6.3.5 Bard Recent Developments/Updates

6.4 Medtronic

6.4.1 Medtronic Company Information

6.4.2 Medtronic Description and Business Overview

6.4.3 Medtronic Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Medtronic Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product Portfolio

6.4.5 Medtronic Recent Developments/Updates

6.5 B. Braun Melsungen AG

6.5.1 B. Braun Melsungen AG Company Information

6.5.2 B. Braun Melsungen AG Description and Business Overview

6.5.3 B. Braun Melsungen AG Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales, Revenue and Gross Margin (2020-2025)

6.5.4 B. Braun Melsungen AG Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product Portfolio

6.5.5 B. Braun Melsungen AG Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Chain Analysis

7.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Production Mode & Process Analysis

7.4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales and Marketing

7.4.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Channels

7.4.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Distributors

7.5 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Customer Analysis

8 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Dynamics

8.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Industry Trends

8.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Drivers

8.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Challenges

8.4 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Boston Scientific

Nano Therapeutics Pvt Ltd

BARD

Medtronic Inc

B Braun Melsungen AG

List of Tables

Table 1. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Competitive Situation by Manufacturers in 2024

Table 4. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Product Type & Application

Table 12. Global Key Manufacturers of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region (2020-2025) & (Units)

Table 18. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Region (2020-2025)

Table 19. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region (2026-2031) & (Units)

Table 20. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Region (2026-2031)

Table 21. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Region (2020-2025)

Table 23. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Region (2026-2031)

Table 25. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2020-2025) & (Units)

Table 27. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2026-2031) & (Units)

Table 28. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2020-2025) & (Units)

Table 32. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2026-2031) & (Units)

Table 33. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2020-2025) & (Units)

Table 42. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2026-2031) & (Units)

Table 43. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (Units) by Type (2020-2025)

Table 51. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (Units) by Type (2026-2031)

Table 52. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Type (2020-2025)

Table 53. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Type (2026-2031)

Table 54. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Type (2020-2025)

Table 57. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Type (2026-2031)

Table 58. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price (USD/Unit) by Type (2020-2025)

Table 59. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price (USD/Unit) by Type (2026-2031)

Table 60. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (Units) by Application (2020-2025)

Table 61. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (Units) by Application (2026-2031)

Table 62. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Application (2020-2025)

Table 63. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Application (2026-2031)

Table 64. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Application (2020-2025)

Table 67. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Application (2026-2031)

Table 68. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price (USD/Unit) by Application (2020-2025)

Table 69. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price (USD/Unit) by Application (2026-2031)

Table 70. Boston Scientific Company Information

Table 71. Boston Scientific Description and Business Overview

Table 72. Boston Scientific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Boston Scientific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product

Table 74. Boston Scientific Recent Developments/Updates

Table 75. Nano Therapeutics Pvt Ltd Company Information

Table 76. Nano Therapeutics Pvt Ltd Description and Business Overview

Table 77. Nano Therapeutics Pvt Ltd Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Nano Therapeutics Pvt Ltd Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product

Table 79. Nano Therapeutics Pvt Ltd Recent Developments/Updates

Table 80. Bard Company Information

Table 81. Bard Description and Business Overview

Table 82. Bard Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Bard Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product

Table 84. Bard Recent Developments/Updates

Table 85. Medtronic Company Information

Table 86. Medtronic Description and Business Overview

Table 87. Medtronic Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Medtronic Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product

Table 89. Medtronic Recent Developments/Updates

Table 90. B. Braun Melsungen AG Company Information

Table 91. B. Braun Melsungen AG Description and Business Overview

Table 92. B. Braun Melsungen AG Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. B. Braun Melsungen AG Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Product

Table 94. B. Braun Melsungen AG Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Distributors List

Table 98. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Customers List

Table 99. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Trends

Table 100. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Drivers

Table 101. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Challenges

Table 102. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters

Figure 2. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Share by Type: 2024 & 2031

Figure 4. Length, ≤10mm Product Picture

Figure 5. Length, ＞10mm Product Picture

Figure 6. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Share by Application: 2024 & 2031

Figure 8. Hospitals

Figure 9. Clinics

Figure 10. Others

Figure 11. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size (2020-2031) & (US$ Million)

Figure 13. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales (2020-2031) & (Units)

Figure 14. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Average Price (USD/Unit) & (2020-2031)

Figure 15. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Report Years Considered

Figure 16. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Share by Manufacturers in 2024

Figure 17. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Players: Market Share by Revenue in Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters in 2024

Figure 19. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Country (2020-2031)

Figure 22. North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Country (2020-2031)

Figure 23. United States Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Mexico Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Country (2020-2031)

Figure 27. Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Country (2020-2031)

Figure 28. Germany Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. UK Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Region (2020-2031)

Figure 35. China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Country (2020-2031)

Figure 45. Latin America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Type (2020-2031)

Figure 55. Global Revenue Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Type (2020-2031)

Figure 56. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Application (2020-2031)

Figure 58. Global Revenue Market Share of Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters by Application (2020-2031)

Figure 59. Global Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Price (USD/Unit) by Application (2020-2031)

Figure 60. Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.